Drug Eluting Stent Delivery System

We have collected information about Drug Eluting Stent Delivery System for you. Follow the links to find out details on Drug Eluting Stent Delivery System.


Drug-Eluting Stent: A Review and Update

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993957/
    Stent-based drug delivery system The main processes of ISR, smooth muscle cell activation and replication, occur locally at the site of injury. Therefore, one of the most logical approaches is a stent-based drug delivery system to locally deliver an appropriate concentration of an effective agent to stop this process without systemic toxicity.Author: Thein Htay, Ming W Liu

EluNIR® Ridaforolimus Eluting Coronary Stent System ...

    https://www.fda.gov/medical-devices/recently-approved-devices/elunirr-ridaforolimus-eluting-coronary-stent-system-p170008
    The EluNIR Ridaforolimus Eluting Coronary Stent System is a drug-coated metal tube used for the treatment of narrowing or blocakages to coronary arteries. The stent is coated with a polymer blend ...

Eluvia™ Drug-Eluting Vascular Stent System - Boston Scientific

    https://www.bostonscientific.com/en-EU/products/stents-vascular/eluvia-drug-eluting-stent-system.html
    An innovative treatment for use in the SFA that pushes patency beyond bare metal and drug-coated stents. The Eluvia Drug-Eluting SFA Stent System demonstrated the highest reported 12 month primary patency of 96.1%.

Drug Eluting Stent Market Size, Share, Trends Global ...

    https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612
    In February 2018, Medtronic launched first 2.0 mm drug eluting stent Resolute Onyx in U.S. Resolute Onyx is a Zotarolimus eluting coronary stent system. Everolimus coated DES have demonstrated clinical effectiveness in reduced vascular inflammation, and rapid endothelialisation.

FDA approves Abbott's latest drug-eluting stent Drug ...

    https://www.drugdeliverybusiness.com/fda-approves-abbotts-latest-drug-eluting-stent/
    May 23, 2018 · FDA approves Abbott’s latest drug-eluting stent May 23, 2018 By Sarah Faulkner Abbott  (NYSE: ABT) said today that it won FDA approval for its Xience Sierra everolimus-eluting coronary stent. The company’s device features a thin profile, improved flexibility and longer lengths than previous stents.

Promus PREMIER™ Drug-Eluting Coronary Stent System ...

    https://www.bostonscientific.com/en-US/products/stents--coronary/promus-premier-stent-system.html
    The C-Code used for the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System is C1874 Stent, coated/covered with delivery system. C-Codes are used for hospital outpatient device reporting for Medicare and some private payers.

Structural and Drug Diffusion Models of Conventional and ...

    https://asmedigitalcollection.asme.org/medicaldevices/article/1/1/47/468096/Structural-and-Drug-Diffusion-Models-of
    Most balloon angioplasty procedures include the insertion of tiny cylindrical wire mesh structures, called cardiovascular stents, into the artery to prevent the elastic recoil thaAuthor: William Jacob S. Dolla, Brian A. Fricke, Bryan R. Becker

Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System ...

    https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160043C.pdf
    The Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System (Resolute Onyx™ system) is a device/drug combination product comprised of the following device components: the Resolute Onyx™ coronary stent and delivery system and a drug component (a formulation of …

Searching for Drug Eluting Stent Delivery System?

You can just click the links above. The data is collected for you.

Related Delivery Info